Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
27,400
+800 (3.01%)
Apr 8, 2026, 3:30 PM KST
Market Cap838.11B +170.8%
Revenue (ttm)566.93B -7.8%
Net Income27.66B
EPS936.77
Shares Out31.51M
PE Ratio28.40
Forward PE20.44
Dividend200.00 (0.75%)
Ex-Dividend DateMar 30, 2026
Volume109,148
Average Volume170,309
Open27,350
Previous Close26,600
Day's Range27,000 - 27,550
52-Week Range10,300 - 45,050
Beta1.19
RSI33.56
Earnings DateMay 8, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements